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Bombardier Enables Delivery of
Short-Form Bomanins in the
Drosophila Toll Response
Samuel J. H. Lin, Amit Fulzele, Lianne B. Cohen, Eric J. Bennett and
Steven A. Wasserman*
Section of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, San Diego,
CA, United States
Toll mediates a robust and effective innate immune response across vertebrates and
invertebrates. In Drosophila melanogaster, activation of Toll by systemic infection drives
the accumulation of a rich repertoire of immune effectors in hemolymph, including
the recently characterized Bomanins, as well as the classical antimicrobial peptides
(AMPs). Here we report the functional characterization of a Toll-induced hemolymph
protein encoded by the bombardier (CG18067) gene. Using the CRISPR/Cas9
system to generate a precise deletion of the bombardier transcriptional unit, we
found that Bombardier is required for Toll-mediated defense against fungi and Gram-
positive bacteria. Assaying cell-free hemolymph, we found that the Bomanin-dependent
candidacidal activity is also dependent on Bombardier, but is independent of the
antifungal AMPs Drosomycin and Metchnikowin. Using mass spectrometry, we
demonstrated that deletion of bombardier results in the specific absence of short-form
Bomanins from hemolymph. In addition, flies lacking Bombardier exhibited a defect in
pathogen tolerance that we trace to an aberrant condition triggered by Toll activation.
These results lead us to a model in which the presence of Bombardier in wild-type
flies enables the proper folding, secretion, or intermolecular associations of short-form
Bomanins, and the absence of Bombardier disrupts one or more of these steps, resulting
in defects in both immune resistance and tolerance.
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INTRODUCTION
Innate immune pathways are found in plants, fungi, and animals and provide a rapid defense
against a broad range of pathogens (1–3). In the fruit fly Drosophila melanogaster, the two major
innate immune pathways are Toll and Imd (4–6). The Toll pathway is activated by Gram-positive
bacteria with Lys-type peptidoglycan and by fungi, and is required for defense against these
microbes (7–10). Conversely, the Imd pathway is activated by and plays a major role in survival
against Gram-negative bacteria and Gram-positive bacteria with DAP-type peptidoglycan (11, 12).
These pathways, which are both mediated by NF-κB transcription factors, are broadly conserved as
initiators of innate immune responses. Activation of either pathway induces robust production of
an array of immune molecules, including antimicrobial peptides (AMPs) (13–17).
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AMPs are found in all kingdoms of life (18–22). These
peptides have long been thought to play the principal effector
role in innate immune defense due to their demonstrated in
vitro antimicrobial activity and their marked upregulation after
infection. However, recent research in D. melanogaster suggests
that AMPs play a major role in Imd-mediated defense, but a
relatively minor role in Toll-mediated immunity (23).
In contrast to the AMPs, the Drosophila-specific Bomanin
peptides (Boms), which are highly induced after infection, are
indispensable for resistance against pathogens controlled by
the Toll pathway (24). Bom155C flies, which lack 10 of the
12 Bom genes, succumb to fungal and Gram-positive bacterial
infections at rates indistinguishable from Toll-deficient flies (23,
24), suggesting that Boms rather than AMPs are the primary
Toll effectors.
Bom peptides, like AMPs, are secreted from the fat body, the
Drosophila immune organ, into the hemolymph, the Drosophila
circulatory fluid. The family is comprised of three groups. The
short-form peptides are 16–17 residues long and contain only the
Bom motif. The tailed forms contain the Bom motif followed by
a C-terminal tail. Finally, the bicipital forms consist of two Bom
motifs connected by a linker region (24). Bom155C flies lack all
six of the short-form Boms, two of the three tailed Boms, and two
of the three bicipital Boms. High-level expression of short-form
Boms is sufficient to rescue the sensitivity of Bom155C flies to C.
glabrata infection (25). Furthermore, the absence of Toll-induced
candidacidal activity in Bom155C hemolymph can be rescued by
high-level expression of a short-form Bom (25). However, no in
vitro antimicrobial activity has been observed with Bom peptides
alone (25), suggesting that the Bomanins act in coordination with
additional humoral effectors.
In this study, we demonstrate an essential role in Toll-
mediated humoral defense for a previously uncharacterized
hemolymph protein, Bombardier (one that deploys Boms).
MATERIALS AND METHODS
CRISPR/Cas9 Deletion of bombardier
Locus
The bombardier gene (CG18067) was deleted using CRISPR/Cas9
technology according to established protocols (26). Briefly, a
pair of gRNAs designed to delete the region 2R: 20,534,248–
20,536,154 were cloned into pU6-BbsI-chiRNA (Addgene
plasmid #45946). Homology arms (1,017 bp left and 1,022 bp
right) were cloned into pDsRed-attP (Addgene plasmid #51019).
The plasmid pBS-Hsp70-Cas9 (Addgene plasmid #46294) was
used as the Cas9 source. Constructs were injected into w1118
embryos. F1 progeny were screened for DsRed eyes and
homozygous lines were established. See Supplemental Table 1
for gRNA and homology arm primer sequences.
Toll Activation, Drosophila Infection, and
Survival Analysis
Flies were raised at 25◦C on cornmeal molasses agar media1.
The w1118 strain was used as the wild type. Microbial isolates,
culture conditions, and conditions for infection for Enterococcus
1http://blogs.cornell.edu/drosophila/dssc-cornmeal-recipe/
faecalis, Enterobacter cloacae, Fusarium oxysporum, and Candida
glabratawere as described previously (24), except that C. glabrata
was concentrated to OD600 = 100. Flies were incubated at 25◦C
after live bacterial infection and at 29◦C after fungal infection.
For heat-killed challenge, bacterial cultures were autoclaved and
resuspended in 20% glycerol to OD600 = 10 for E. faecalis
and OD600 = 300 for M. luteus. For both survival assays
and hemolymph preparation, flies challenged with heat-killed
bacteria were incubated at 29◦C.
Hemolymph Antimicrobial Assays
Candidacidal activity of hemolymph was assayed as described
previously (25), except that hemolymph was prepared from
groups of 30 flies and all activity assays were carried out for
1 h at room temperature. The number of colonies representing
zero percent killing was set as the value obtained by assaying
uninduced w1118 hemolymph.
MALDI-TOF Analysis of Hemolymph
The Toll pathway was activated in flies using heat-killed M.
luteus, then incubated at 29◦C for 24 h. Hemolymph was
extracted as in Lindsay et al. (25), with slight modifications.
Hemolymph extracted with glass capillaries from five male
flies was pooled and transferred into 0.1% trifluoroacetic acid
(TFA)/50% acetonitrile (ACN). One µl of each mixture was
spotted on a Bruker MSP 96 ground steel plate, mixed 1:1
with a saturated solution of Universal MALDI matrix (Sigma-
Aldrich) in 0.1% TFA/78% ACN, and air-dried. MALDI-
TOF spectra were acquired using a Bruker Autoflex mass
spectrometer. Data were collected from 1,500 to 10,000 m/z
in positive linear mode, and 1,000–5,000 m/z in positive
reflectron mode. Peptide calibration standard II (Bruker) was
mixed with Universal MALDI matrix and used as an external
calibration standard. At least ten independent samples were
collected for each genotype. For peptide identification, peaks
were matched to those of corresponding peaks in prior studies
(13, 25). Representative spectra were visualized using R 3.3.2 and
ggplot2 2.2.1 (27, 28).
Gene Expression Quantitation
The Toll pathway was activated with heat-killed M. luteus.
Using TRIzol (Ambion), total RNA was extracted 18 h after Toll
activation from four to six adult flies (2–5 days old). Next, cDNA
was synthesized from 500 ng total RNA using the SuperScript
II Reverse Transcriptase kit (Invitrogen). Quantitative RT-
PCR was performed on an iQ5 cycler (BioRad) using iQ
SYBR Green Supermix (BioRad). Quantification of mRNA
levels was calculated relative to levels of the ribosomal protein
gene rp49 using the Pfaﬄ method (29). Three independent
replicates were completed. See Supplemental Table 1 for qPCR
primer sequences.
Hemolymph LC-MS
Flies were challenged with heat-killed M. luteus to activate
the Toll pathway. Hemolymph was extracted from 100 to
110 each of w1118, 1bbd, and Bom155C flies using the same
method as in the hemolymph antimicrobial assays, with 50–
60 flies processed per Zymo-Spin IC column (Zymo Research)
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and yielding a total of ∼10 µl hemolymph per genotype.
Three independent biological replicates were processed for
1bbd and Bom155C, and two independent biological replicates
were processed for w1118. Extracted hemolymph was mixed 1:1
(vol/vol) with denaturing buffer (8M Urea, 50mM Tris, pH
7.8, 150mM NaCl, protease and phosphatase inhibitors) and
protein concentration was determined using a BCA assay. For
each sample, 40 µg of hemolymph was diluted to 1M urea
using 50mM ammonium bicarbonate and digested overnight
with trypsin (Promega, V511A) at a 1:100 (trypsin:protein) ratio.
After digestion, peptides were reduced with 1mM dithiothreitol
at room temperature for 30min and then alkylated with 5mM
iodoacetamide at room temperature in the dark for 30min.
Formic acid was added to a 0.1% final concentration and
peptides were desalted using the C18-Stage-Tip method and
then vacuum dried. The dried peptides were reconstituted in
5% formic acid/5% acetonitrile and 1 µg of total peptide for
each sample was loaded for MS analysis. Samples were run in
technical triplicates on a Q-Exactive mass spectrometer with
instrument and chromatography settings as described previously
(30), except for the following modifications: the RAW files
were analyzed using Andromeda/MaxQuant (version 1.6.7.0)
(31) with default settings (32) except the match between the
run and LFQ quantitation settings was enabled for label free
quantification. Data were searched against a concatenated target-
decoy database comprised of forward and reversed sequences
from the unreviewed UniprotKB/Swiss-Prot FASTA Drosophila
database (2019). A mass accuracy of 20 ppm was assigned
for the first search and 4.5 ppm for the main search. The
statistical analysis was calculated using the DEP analysis
R-package (33).
Bacterial Load Quantification
Bacterial load upon death (BLUD) was obtained as in Duneau
et al. (34), with slight modifications. Briefly, flies were infected
with E. faecalis and vials were monitored every 30min for
newly dead flies. These flies were then individually homogenized
with a pestle in 400 µl LB media. Homogenates were
also prepared from individual live w1118 flies 120 h post-
infection (hpi). Homogenates were diluted serially in LB and
spread on LB agar plates for incubation at 37◦C overnight.
Colonies were counted manually and the number of viable
bacteria per fly was calculated. Data were obtained from three
independent experiments.
Data Analysis
GraphPad Prism 5 was used for statistical tests. Survival
data were plotted as Kaplan-Meier curves and were analyzed
using the Gehan-Breslow-Wilcoxon test to determine statistical
significance. Statistical differences in candidacidal activity
were calculated using one-way ANOVA followed by Tukey’s
test. Multiple Mann-Whitney U tests were used to calculate
differences between BLUD samples (p = 0.0085 after Šidák
correction for multiple comparisons, α= 0.05, k= 6). Spearman
rank correlation was used to assess the relationship between
BLUD and time of death.
RESULTS
The bombardier Gene Is Specifically
Required for Toll-Mediated Defense
The bombardier (bbd) gene contains a consensus Toll-responsive
NF-κB binding site within its promoter region and is strongly
expressed upon Toll activation by Gram-positive bacterial
infection or other inducers (14, 17, 35, 36). The encoded protein
is predicted to be secreted and to generate a mature protein of
222 amino acids with a coiled coil near its C-terminus (37, 38).
Orthologs of Bombardier are found across the Drosophila genus,
but in no other genera (39).
We began our analysis of the bombardier gene by
generating a null mutant, using CRISPR/Cas9 to delete
1,906 bp encompassing the annotated transcriptional unit. Flies
homozygous for this deletion (hereafter 1bbd) were viable
and morphologically wild-type. Given that bombardier is Toll-
inducible, we assayed 1bbd flies for a potential loss-of-function
phenotype in Toll-mediated immunity. Specifically, we infected
adult 1bbd flies with various pathogens and then monitored
survival. Two additional genotypes were used as controls: w1118
flies, which served as the wild type, and Bom155C flies, which
lack Toll-mediated humoral defenses due to deletion of the 10 of
the 12 Bom genes (24).
As shown in Figure 1, we observed a marked
immunodeficiency when 1bbd flies were challenged with
representative species for the three classes of microbes against
which Toll provides defense. With the yeast Candida glabrata,
more than 90% of w1118, but no 1bbd flies, survived 5 days after
infection (Figure 1A). In the case of the filamentous fungus
Fusarium oxysporum, 70% of w1118 adults, but fewer than 20%
of 1bbd adults, were alive 5 days post-infection (Figure 1B).
Finally, with Enterococcus faecalis, a Gram-positive bacterium,
50% of wild-type flies, but no 1bbd flies, were alive 5 days after
infection (Figure 1C).
The impairment of Toll-mediated defenses by deletion of
bombardier was significant for all three pathogens (p < 0.0001).
In the case of C. glabrata, the immunodeficiency of 1bbd
phenocopied that observed for Bom155C flies (n.s., p > 0.05). In
contrast, with either F. oxysporum or E. faecalis, the rate of death
was greater for Bom155C than for 1bbd (∗∗∗p < 0.0001 for both
infections). The1bbdmutant thus displays a substantial, but not
complete, loss of Toll-mediated defense.
The expression of bombardier is strongly induced by Toll, but
not Imd activation (14). We therefore hypothesized that Imd-
mediated defenses would not require bombardier function. To
test this prediction, we infected 1bbd flies with Enterobacter
cloacae, a Gram-negative bacterium. In this experiment, 1bbd
flies were as immunocompetent as w1118 flies: more than
90% of both genotypes survived at least 5 days post-infection
(Figure 1D). In contrast, 100% of RelE20 flies, which are
deficient in Imd signaling (40), succumbed to infection within
1 day. Thus, bombardier functions in defense against a
range of pathogens for which Toll mediates defense—yeast,
filamentous fungi, and Lys-type Gram-positive bacteria—but not
against Gram-negative bacteria, against which the Imd pathway
is active.
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FIGURE 1 | The bombardier gene is specifically required for Toll-mediated defense. (A–D) Survival curves of flies infected as indicated. The w1118 strain was the
wild-type control; Bom155C and RelE20 were the susceptible controls (24, 40). Experiments were completed in triplicate with at least 25 flies per genotype in each
replicate. Statistical significance was determined using the Gehan-Breslow-Wilcoxon test and 1bbd is shown relative to w1118 in black, relative to Bom155C in orange,
and relative to RelE20 in red (***p < 0.0001; n.s., not significant, p > 0.05).
The Candidacidal Activity of Hemolymph
Requires Bombardier, but Neither
Drosomycin Nor Metchnikowin
Next, we investigated the potential humoral role of Bombardier
by preparing and assaying cell-free hemolymph. We have
previously shown that hemolymph from wild-type flies exhibits
a Toll-dependent and Bomanin-dependent candidacidal activity
(25). However, we were also curious as to the identity of
the active antifungal component. In particular, we considered
the potential role of Metchnikowin (Mtk) and Drosomycin
(Drs), two antimicrobial peptides (AMPs) that have documented
antifungal activity in vitro and are strongly Toll-induced in
vivo (14, 41, 42). We therefore took advantage of the recently
described 1AMPs strain, which is deficient for Mtk and Drs, as
well as all other induced AMPs other than the Cecropins (23).
Extracting and assaying Toll-induced hemolymph, we found that
hemolymph from 1AMPs flies had a killing activity against C.
glabrata comparable to that of wild-type hemolymph (Figure 2).
In contrast, we failed to detect any killing of C. glabrata by
1bbd hemolymph. We conclude that Boms and Bombardier, but
neither Mtk nor Drs, are required for humoral defense against
C. glabrata.
Short-Form Bom Peptides Are Specifically
Absent From 1bbd Hemolymph
MALDI-TOF provides a robust tool for characterizing small
(<5,000 MW) peptides present in hemolymph after Toll
activation. As shown in Figures 3A,B, such a readout includes
the aforementioned AMPs (Mtk and Drs), several short-form
Boms (BomS1, S2, S3, and S6; see Supplemental Table 2 for
updated Bomanin nomenclature), and other induced peptides
(e.g., IM4). We have previously shown that deleting the 55C
Bom gene cluster removes the peaks attributable to the short-
form Boms, while leaving the remaining signals unaffected (25).
Remarkably, analysis of 1bbd hemolymph yielded a similar
pattern. As shown in Figures 3C,D, the short-form Boms that
were readily detectable in the wild type—S1, S2, S3, and S6—were
absent in 1bbd hemolymph, whereas the remaining peptides,
including Mtk, Drs, and IM4, displayed a wild-type profile.
Although 1bbd disrupts the accumulation of short-form
Bom peptides in hemolymph, this effect does not reflect a
disruption in transcription or stability of the corresponding
BommRNAs: robust induction of Toll-regulated genes, including
genes of short-form Boms, was readily detectable with qRT-PCR
(Supplemental Figure 1).
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FIGURE 2 | The Toll-induced candidacidal activity of hemolymph requires
Bombardier, but neither Drosomycin nor Metchnikowin. Heat-killed M. luteus
was used to activate the Toll pathway in flies. Hemolymph was extracted from
flies 24 h after Toll induction, mixed with C. glabrata and incubated for 1 h to
allow for killing. The surviving yeast cells were plated, and colonies were
counted to determine the level of candidacidal activity in the extracted
hemolymph. Colony counts from uninduced w1118 hemolymph were used as
the control for no (0%) killing. Experiments were completed four times, with
each point representing one replicate. One-way ANOVA was calculated
followed by Tukey’s test. Significance is shown relative to the null hypothesis of
0% killing (***p < 0.0001; n.s., not significant, p > 0.05). Error bars represent
the 95% confidence interval.
Because proteins such as Bombardier and bicipital Boms
are too large to be detected by our MALDI-TOF protocol, we
used LC-MS to further characterize the relationship between
Bombardier and the Boms in hemolymph. For these studies,
we prepared Toll-induced hemolymph from three genotypes:
w1118, 1bbd, and Bom155C. In wild-type hemolymph, we
readily detected Bombardier protein (Figure 4), consistent with
the presence of a canonical secretion signal sequence in the
Bombardier coding sequence. Bombardier, like the Boms, is thus
secreted into hemolymph upon Toll induction. We also detected
all three bicipital Boms—BomBc1, BomBc2, and BomBc3. The
LC-MS studies thus complemented the MALDI-TOF studies,
with bicipital Boms detected by the former and short-form Boms
by the latter (tailed Boms are not detected by either protocol).
Next, we assayed 1bbd hemolymph. As expected, Bombardier
was not detected. However, the three bicipital Boms were present
at comparable levels in wild-type and 1bbd hemolymph (see
Figure 4). Combined with the MALDI-TOF studies, these results
demonstrate that 1bbd blocks accumulation in hemolymph
of short-form, but not bicipital, Boms. Lastly, we analyzed
hemolymph from Bom155C flies, which lack 10 of the 12 Bom
genes. As expected, the products of the two deleted bicipital
genes (BomBc1 and BomBc2) were absent, whereas the product of
the remaining bicipital gene (BomBc3) was present at wild-type
levels (see Figure 4). Turning our attention to Bombardier, we
observed no effect of the 55C Bom deletion. Thus, Bombardier is
required for the presence of short-form Boms in hemolymph, but
the 55C Boms are not required for the presence of Bombardier.
Bombardier Mediates Both Infection
Resistance and Tolerance
The 1bbd survival phenotype could be due to an inability to
control pathogen growth—a defect in resistance—or an inability
to endure infection—a defect in tolerance. Because flies lacking
Bombardier demonstrate an increased susceptibility to infection
and decreased levels of known resistance factors, the short-
form Boms, it seemed likely that 1bbd flies, like Bom155C
flies, have a defect in infection resistance. In exploring this
hypothesis, we found that the model recently developed by
Duneau et al. provided a useful framework (34). Following
infection of an individual fly, there are two stereotypic outcomes:
either the pathogen replicates, reaches a lethal burden, and the
fly dies; or the pathogen is controlled at a level below the
lethal burden and the fly survives with a persistent infection.
Variation in survival curves for different pathogens and fly
genotypes reflects variation in both the time required to
reach lethal burden and in the fraction of flies that are able
to control the infection before it reaches such a threshold.
In cases where a fraction of flies control infection, group
survival typically drops after infection and then reaches a
plateau (23).
The survival curve for 1bbd flies infected with E. faecalis
does not plateau (see Figure 1C). Instead, it exhibits a profile
that we hypothesize reflects two phases of death. In the
first phase, extending roughly 2 days post-infection, some
1bbd flies reach a lethal burden of E. faecalis and die, as
reflected in a sharp decline in survival; the remainder control
the infection. In the second phase, from 2.5 days onward,
those flies with a persistent infection die at a reduced but
steady rate, due to a defect in tolerance. If this hypothesis
is correct, flies dying in the first phase should have a
bacterial load upon death (BLUD) comparable to that of
wild-type flies dying from infection. Furthermore, those dying
in the second phase should have a much lower pathogen
burden, comparable to that of wild-type survivors with a
persistent infection.
To test our predictions regarding pathogen burden, we
measured the BLUD of individual flies after infection with
live E. faecalis and divided the data into two time intervals
(Figure 5). For the earlier interval (dead flies obtained between
17 and 51.5 hpi), both Bom155C and 1bbd bacterial loads upon
death were not significantly different from w1118 (Figure 5, red,
p > 0.05). For the later time interval (flies obtained between
68 and 120.5 hpi), 1bbd flies perished at significantly lower
bacterial loads compared to that of 1bbd flies which died earlier
(Figure 5, 1bbd early compared to 1bbd late, p < 0.0001),
indicating that these two groups die from distinct causes.
Importantly, late-death 1bbd flies perished at significantly
lower bacterial loads than those of w1118 suffering early deaths
(p < 0.0001), demonstrating that 1bbd flies have a defect
in tolerance.
Together, the survival curve and BLUD data offer strong
support for our two-phase-model: 1bbd flies died early in
infection with high bacterial loads, due to a defect in resistance,
and died later with lower bacterial loads, reflecting a deficiency
in tolerance. However, we note that the bacterial loads of
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FIGURE 3 | Short-form Bom peptides are specifically absent in hemolymph from 1bbd flies. MALDI-TOF mass spectra of w1118 (A,B) and 1bbd (C,D) hemolymph
samples were collected in linear (A,C) and reflectron mode (B,D). For peptide identification, peaks were matched to those of corresponding peaks in prior studies
(13, 25). Spectra were obtained from at least ten independent biological replicates and representative spectra are shown (a.u., arbitrary units; m/z, mass/charge).
FIGURE 4 | The presence of bicipital Bomanins in hemolymph is unaffected
by loss of Bombardier. MS/MS counts for the indicated proteins as determined
by Andromeda/MaxQuant were normalized to total MS/MS counts in each
run. Error bars represent standard deviation for biological replicates (n = 3 for
1bbd and Bom155C, n = 2 for w1118). Supplemental Table 3 shows the
full dataset.
1bbd flies dying in the later phase were still significantly
greater than those of w1118 flies alive 120 hpi (Figure 5, 1bbd
late compared to live w1118, p < 0.0001). This indicates that
the later-death 1bbd group has not completely controlled
infection compared to the live w1118 flies, and suggests that both
resistance and tolerance contribute to the later 1bbd fly deaths.
Although we cannot rule out a minor resurgence in bacterial
proliferation preceding late death of bbd flies, we note that
BLUD and time of death were not significantly correlated for
these flies (Supplemental Figure 2, Spearman correlation test,
r =−0.2654, p= 0.1564).
Immune Activation, Specifically Bom
Expression, Is Deleterious in the Absence
of Bombardier
What is the nature of the tolerance defect we observed in
1bbd flies? More specifically, is their health impaired by an
excessive or toxic immune response, or is death due to another
class of impaired tolerance (43)? To distinguish between these
explanations, we assayed the effect of activating the immune
response in1bbd flies in the absence of infection.
When 1bbd flies were challenged with heat-killed E. faecalis,
we observed a decrease in survival that first was apparent 3 days
post-challenge followed by a steady decline in the number of live
flies in the following days (Figure 6A), consistent with the timing
of the late-phase deaths (see Figure 5). Overall, the death rate
was slower than that of live infection, but the extent of killing
was similar between heat-killed and live E. faecalis: fewer than
20% of flies survived (compare Figures 1C, 6A). In contrast, no
effect on survival was observed upon challenge of either w1118
or Bom155C flies with heat-killed E. faecalis: >95% flies survived
seven or more days post-challenge.
The effect of immune stimulation on 1bbd survival was
not specific to E. faecalis. When we repeated the challenge
experiments with heat-killed Micrococcus luteus, which activates
the Toll response [see Supplemental Figure 1, as well as (25, 44)],
the effect on 1bbd survival was again marked: 5 days after
challenge, fewer than 5% of 1bbd flies were alive, compared to
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FIGURE 5 | Bombardier mediates both infection resistance and tolerance.
Bacterial load upon death (BLUD) of w1118, Bom155C, and 1bbd flies, plotted
by early (17–51.5 hpi, red) or late (68–120.5 hpi, orange) time of death
post-infection, as well as bacterial load of live w1118 flies 120 hpi (blue). Data
was obtained and combined from three independent experiments totaling
n = 26 for w1118, n = 30 for Bom155C, n = 33 for 1bbd red, n = 30 for 1bbd
orange, and n = 29 for live w1118. Black bars indicate median values. Statistics
were calculated using multiple Mann-Whitney U-tests. For significance,
p = 0.0085 after Šidák correction for multiple comparisons (α = 0.05, k = 6).
The pathogen loads of early deaths for Bom155C and 1bbd were not
significantly different from w1118 (p > 0.05). The pathogen load of late 1bbd fly
deaths is significantly different from that of the early-death 1bbd and w1118
groups (***p < 0.0001) and also significantly different from that of live w1118
flies 120 hpi (***p < 0.0001). Finally, the early-death w1118 pathogen load was
significantly different from that of live w1118 flies 120 hpi (***p < 0.0001) (hpi,
hours post-infection).
survival of >95% of w1118 and 85% of Bom155C flies over the
same period of time (Figure 6B).
As bothM. luteus and E. faecalis induce the Toll pathway, Toll
activation could be the key factor in 1bbd mortality. To address
this hypothesis, 1bbd flies were crossed with MyD88kra1 (Toll-
deficient) flies to generate the MyD88kra1 1bbd double mutant,
and the resulting flies were challenged with heat-killed E. faecalis
andM. luteus. Unlike1bbd flies,MyD88kra1 1bbd flies survived
challenge with Toll activators (Figures 7A,B). Because blocking
the Toll pathway with MyD88kra1 rescues the 1bbd phenotype
triggered by heat-killed bacteria (p < 0.0001 compared to 1bbd,
p > 0.05 compared to MyD88kra1 for both heat-killed bacteria),
we conclude that Toll activation underlies the death of1bbd flies
in the absence of infection.
As described above, Bom genes are transcribed in 1bbd flies
(Supplemental Figure 1), but short-form Bom peptides do not
appear in hemolymph (Figure 3). This suggests a mislocalization
of these peptides, perhaps in an unprocessed or misfolded
state. Given that short-form Bom genes are among the most
abundantly transcribed genes after infection (17, 36), such
mislocalized or misfolded Boms could rapidly accumulate to
high levels in 1bbd flies. Could this explain the death of
1bbd flies upon immune stimulation? To address this question,
we generated Bom155C 1bbd double mutants and assayed the
effect of immune induction alongside both Bom155C and 1bbd
flies (Figures 7A,B). The result was unequivocal: introducing
Bom155C, which deletes all of the short-form Boms, eliminated
the effect of 1bbd on survival following immune stimulation
(p < 0.0001 compared to 1bbd, p > 0.05 compared to Bom155C
for both heat-killed bacteria). The fact that Bom155C is epistatic
to 1bbd demonstrates that Toll-driven expression of Bom genes
is specifically responsible for the death of immune-stimulated
1bbd flies.
DISCUSSION
The results presented in this study identify a key factor that
regulates humoral and Bom-mediated defense in Drosophila.
We demonstrate that 1bbd flies are defective in resistance to
pathogens controlled by the Toll pathway. The results support
the hypothesis that this defect results from the absence of short-
form Boms in1bbd hemolymph. Absence of Boms is sufficient to
cause a defect in resistance (24) and1bbd hemolymph appears to
be lacking the short-form Boms but no other component, save
Bombardier itself. Furthermore, 1bbd phenocopies Bom155C
with regard to survival after C. glabrata infection, and resistance
to C. glabrata can be restored in Bom155C flies by expression
of short-form Boms (25). Finally, 1bbd hemolymph lacks
candidacidal activity, which is dependent on short-form Bom
peptides (25) and which we show here does not require Drs
or Mtk.
For pathogens other than C. glabrata, the effect of deleting
Bombardier is less severe than that of deleting the ten Bom
genes clustered at 55C. Our mass spectrometry data suggest
an explanation. Whereas, short-form Boms are absent from
1bbd hemolymph, bicipital Boms are present. (Tailed Boms
were not detected with either mass spectrometry method.)
Therefore, we postulate that the bicipital Boms, which are not
required for resistance to C. glabrata (25), are functional against
other pathogens. This would explain why 1bbd flies are more
resistant than Bom155C flies upon infection with E. faecalis or F.
oxysporum (Figure 1). In this regard, we note that Bombardier
and all three forms of Bom proteins—short, tailed, and bicipital—
are found across theDrosophila genus, supporting the notion that
all three classes of Boms are immunoprotective and therefore
maintained across the Drosophila genus.
It might appear that our discovery of Bombardier was
serendipitous, given our role in defining the Bomanin gene
family (24, 25). In hindsight, however, the link was forged in
our approach. We selected CG18067 from the most strongly
inducible Toll-regulated loci, a group that also includes eight
of the Bomanin genes. Next, we engineered a CRISPR/Cas9
deletion of CG18067 and assayed this knockout with the
identical set of pathogens that we had used for the Bom155C
deletion, screening for loss of survival upon infection. Having
examined a gene that is as strongly induced as the Bomanins,
present in the same range of species as the Bomanins,
and with a spectrum of loss-of-function phenotypes similar
to that of the Bomanins, it is not particularly surprising
that we would find ourselves studying a gene that affects
the Bomanins.
Bombardier Function and Structure
What is the function of Bombardier? Deleting the gene results
in the absence of short-form Boms from hemolymph, an effect
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A B
FIGURE 6 | Immune activation is deleterious in absence of Bombardier. Fly survival after introduction of (A) heat-killed E. faecalis and (B) heat-killed M. luteus.
Experiments were completed in triplicate with at least 25 flies per genotype in each replicate. Statistics were determined using the Gehan-Breslow-Wilcoxon test.
Significance is shown relative to w1118 (***p < 0.0001; n.s., not significant, p > 0.05).
A B
FIGURE 7 | Toll-induced Bom expression is responsible for death in immune stimulated 1bbd flies. Survival of flies challenged with (A) heat-killed E. faecalis and (B)
heat-killed M. luteus. Experiments were completed in triplicate with at least 25 flies per genotype in each replicate. Statistics were determined using the
Gehan-Breslow-Wilcoxon test. Significance of double mutant survival curves is shown relative to the survival curve of 1bbd (***p < 0.0001).
we find is at the level of protein. Other mature immune peptides
are present at normal levels in the hemolymph, and there is
thus no general defect in translation, secretion, or processing.
Based on these findings, we propose that Bombardier normally
functions either to chaperone short Boms as they are secreted
from the fat body into the hemolymph or, alternatively, to
protect the Boms from misfolding or aggregation while in
the hemolymph. We further hypothesize that it is the ectopic
localization or aberrant form of short-form Boms in 1bbd
flies that generates morbidity upon Toll pathway activation.
In support of this idea, we showed that Bom expression
underlies the lethality observed in1bbd flies (Figure 7).Whether
the short-form Boms physically interact with Bombardier,
perhaps in the context of a larger antimicrobial complex, is
currently unknown.
Activation of Toll-like receptor (TLR) signaling is important
for innate immunity, but induction of the pathway can
lead to autoimmune disorders and chronic inflammatory
disease (45–48). Here we report an autoimmune activity
driven by Toll-induced Bom expression in flies lacking a
downstream pathway component, Bombardier. To what extent
this parallel can be exploited in the context of understanding
autoimmune disorders promises to be a significant focus for
future investigation.
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